US2016009794A1PendingUtilityA1
Antibody to n-terminal region of hemoglobin beta-chain
Est. expiryDec 11, 2028(~2.4 yrs left)· nominal 20-yr term from priority
C07K 2317/14G01N 33/531C07K 2317/33C07K 14/805C07K 16/18C12N 5/163C07K 2317/34G01N 33/723G01N 33/721
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided is a general-purpose technique capable of measuring the HbA1c content, which is comparable to the IFCC reference method. An antibody which reacts with a peptide or a protein having an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein in which the N-terminal valine of the relevant polypeptide or protein is modified.
Claims
exact text as granted — not AI-modified1 . An antibody which reacts with a peptide or a protein comprising an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein comprising an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is modified.
Join the waitlist — get patent alerts
Track US2016009794A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.